A study demonstrated that p16-positive senescent fibroblasts were selectively killed by a senolytic cocktail that decreased the profibrotic effects of the SASP and improved pulmonary function and physical health in a bleomycin-injury IPF model1. Here, CDKN2A is linked to idiopathic pulmonary fibrosis.